Lupin is currently trading at Rs. 719.75, up by 4.40 points or 0.62% from its previous closing of Rs. 715.35 on the BSE.

The scrip opened at Rs. 720.00 and has touched a high and low of Rs. 726.35 and Rs. 712.55 respectively. So far 13667 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 914.20 on 03-Oct-2018 and a 52 week low of Rs. 697.30 on 19-Jun-2019.

Last one week high and low of the scrip stood at Rs. 740.00 and Rs. 702.05 respectively. The current market cap of the company is Rs. 32633.62 crore.

The promoters holding in the company stood at 46.96%, while Institutions and Non-Institutions held 38.66% and 14.38% respectively.

Pharmaceutical and Medical Devices Agency (PMDA), Japan has completed Good Manufacturing Practices (GMP) inspection at Lupin’s Goa facility (Unit - I & II). The inspection was conducted between September 24, 2019 and September 27, 2019. The PMDA inspection closed with no critical or major observations.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Lupin Share Price

2055.05 3.00 (0.15%)
10-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.25
Dr. Reddys Lab 1251.10
Cipla 1489.15
Zydus Lifesciences 923.70
Lupin 2055.05
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×